SNWVSNWVHealthcare · Medical Devices

SNWV Stock Forecast: SANUWAVE Health, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$1.50
−5.66% on the day

Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 53 of 100 as at 21 Nov 2026 — in the upper half.

Market cap
$12.9M
Ticker Nerd rank
53/ 100
Median analyst target
—
Analysts covering
1
Revenue$9.7M−4.2% y/y
Operating income−$280K
Net income−$682K
Free cash flow−$22K
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−17.6%
1M
−71.5%
YTD
−95.0%
1Y
−95.3%
From 52W high
−95.7%
From 52W low
0.0%
$2
$35
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores SANUWAVE Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
53/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
99
Issuance
79
Value
73
Growth
51
Accruals
43
Revisions
20
Volatility
18
Momentum
2

Quality (99): The business earns solid, repeatable profits on what it owns.

Momentum (2): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

SNWV stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SNWV, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0$10$20$30$40Jan 26Apr 26Jul 26Oct 26SNWV

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says1 analysts
1
Buy
0
Hold
0
Sell
Recent analyst actionsNewest first
DateFirmActionRatingTarget
30 Mar 2026Roth CapitalReiteratesBuy$53 → $47
3 Sept 2025Northland Capital MarketsInitiatesOutperform—
22 Aug 2025Roth CapitalMaintainsBuy—
29 July 2025Roth CapitalInitiatesBuy—
15 Sept 2020Lake StreetInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for SNWV.

Market Radar

This page is one stock. Monday covers all of them.

SNWV appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

SNWV vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, SANUWAVE Health, Inc. returned −95.3% against +6.9% for the S&P 500, dividends included.

SNWV vs S&P 500, last 12 monthsTotal return, rebased to 100
020406080100120Jan 26Apr 26Jul 26Oct 26SNWVS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

SNWV analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
0
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
0.3×

Cheaper than 86% of US stocks

Price / book
4.5×

Cheaper than 20% of US stocks

EV / EBITDA
11.0×

Cheaper than 51% of US stocks

Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
76.2%

Higher than 88% of US stocks

Operating margin
2.6%

Higher than 47% of US stocks

Net margin
—
Returns & dividend
Return on equity
729.6%

Higher than 99% of US stocks

Return on assets
2.0%

Higher than 58% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • SANUWAVE Health, Inc. has a market value of $12.9M and an enterprise value of $25.9M.

  • Revenue in the twelve months to 30 June 2026: $43.9M. The latest quarter shrank 4.2% year on year.

  • Net income over the same four quarters: $14.3M, a 32.6% net margin.

  • Free cash flow in the twelve months to 30 June 2026: $4.0M.

  • Shares outstanding: 8.6M.

  • SANUWAVE Health, Inc. employs 55 people — $798K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

SNWV and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
SNWVSANUWAVE Health, Inc.$12.9M53
CTSOCytoSorbents Corp.$13.1M70
CVRXCVRx, Inc.$14.3M20
ITOCiTonic Holdings Ltd.$11.6M15
MODDModular Medical, Inc.$16.0M12
HSCSHeartSciences, Inc.$10.3M43
NNOXNano-X Imaging Ltd.$17.7M17

Take a look at SNWV’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own SANUWAVE Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about SNWV

Is SNWV stock a buy right now?

Of the 1 analyst covering SANUWAVE Health, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SANUWAVE Health, Inc. 53 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank SNWV?

As at 21 Nov 2026, SANUWAVE Health, Inc. ranks 53 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Quality (99 of 100).

What is the SNWV stock forecast for 2030?

No analyst covering SANUWAVE Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SNWV are extrapolating price history, which says nothing about the business.

How has SNWV stock performed over the past year?

SANUWAVE Health, Inc. returned -95.3% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does SANUWAVE Health, Inc. do?

SANUWAVE Health, Inc. Common Stock represents a medical device company focused on noninvasive energy-based therapies for wound care and regenerative healing. SANUWAVE develops and markets ultrasound and shockwave systems designed to support the treatment of acute and chronic wounds, with its UltraMIST platform serving as a key commercial product.

Company

About SANUWAVE Health, Inc.

SANUWAVE Health, Inc. Common Stock represents a medical device company focused on noninvasive energy-based therapies for wound care and regenerative healing. SANUWAVE develops and markets ultrasound and shockwave systems designed to support the treatment of acute and chronic wounds, with its UltraMIST platform serving as a key commercial product. The company also works in related areas such as tissue, musculoskeletal, and vascular repair, positioning its technologies within advanced wound management and regenerative medicine. Its business is centered on designing and selling medical devices to healthcare providers, with products used in clinical settings that require targeted, non-contact therapeutic solutions. SANUWAVE Health, Inc. Common Stock is associated with a healthcare technology business that addresses specialized treatment needs across wound care and tissue recovery markets.

CEO Mr. Morgan C. Frank · 55 employees · United States · https://sanuwave.com